Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New herbal drug therapy effective in treating vascular dementia

11.06.2003


American Heart Association meeting report



For centuries, the herb Chinese gastrodine has been used in China to treat disorders such as dizziness, headache and even ischemic stroke. Research presented today at the American Heart Association’s Second Asia Pacific Scientific Forum shows treatment with a gastrodine compound granule is effective in improving impaired memory, orientation, language and other effects of stroke in patients who were diagnosed with mild to moderate vascular dementia (VaD) after their stroke.

Vascular dementia is one of the most common dementias ranked after Alzheimer’s disease. It’s a growing problem in China, with a prevalence of about one to three percent, similar to prevalence rates in the United States and Europe. Because some medications for the condition are very expensive for most patients in China, researchers focused on finding treatments that would be effective and less costly. Chinese herbal medicines not only are less expensive and have fewer side effects than standard chemical medications, but they are also more accepted by the Chinese people, according to lead researcher Jinzhou Tian, M.D., Ph.D., director of the Institute of Geriatrics, Beijing University of Chinese Medicine.


For this study, researchers selected the gastrodine compound granule. It’s extracted from tall gastrodia tuber plants and six other herbs and is the first of new herbal drugs in dementia to be tested in clinical trials. The 12-week, randomized, double-blind trial was done in Beijing Dongzhimen Hospital, one of the hospitals running the clinical trials between 1999 and 2002. Researchers identified 120 stroke patients (75 male 45 female) who were diagnosed with mild to moderate VaD lasting three months or more. All patients were assessed for VaD at baseline and randomly divided into two treatment groups. One group (70 patients) was given one bag of the gastrodine compound granule (2.6 milligram gastrodine) three times a day for 12 weeks. The second group (50 patients) was given 40 mg of Duxilâ (almitrine + raubasine) three times a day for 12 weeks. This is a drug used to treat stroke patients in China. Both the gastrodine compound granule and the Duxilâ granule were dissolved in hot water and given orally.

In the gastrodine group, there were significant increases of the average MMSE (mini-mental state exam) score compared to baseline scores (20.83 vs.18.96). In the areas of memory, orientation, calculation, and language, the MMSE showed similar improvement in both groups.

However, the gastrodine group showed a significant difference in the Blessed Behavioral Scale (BBS) score - including behavior, activities of daily living, and personality - between endpoint (15.72) and baseline (18.76), as well as at endpoint (17.08) in the Duxilâ group. A score greater than or equal to 16 is abnormal and a score less than 16 is normal. The gastrodine group also suffered fewer side effects. Researchers say combined results showed the gastrodine group improvement was 51.43 percent, with 16 of the 70 cases showing much improvement, 20 cases with some improvement, and 34 cases with no change. The improvement rate for patients treated with Duxilâ was 52 percent, with seven of the 50 cases showing much improvement, 19 cases with some improvement, and 24 cases with no change.

The study also found that the gastrodine treatment may increase regional cerebral blood flow in VaD patients, but Tian says further study is needed to determine other benefits. Researchers also say a study of six months or more is needed to further determine the clinical effectiveness of the gastrodine compound granule for treating mild to moderate VaD. Given the positive results in the areas of memory and behavior, they say further research into herbal therapies for VaD may also be warranted.

"Chemical drugs, such as cholinesterase inhibitors, are effective in the treatment of cognitive and memory function in dementia, but these drugs are expensive and have side effects," says Tian. "This study might result in doctors considering the use of herbal medications, such as gastrodine compound granules to supplement the treatment of mild and moderate cognitive impairment in primary care for the elderly with cerebral ischemic damage."


Co-authors are Aihua Zhu, Jing Shi, Junxiang Yin, Jian Zhong, Chengzhi Yang, Shuliang Peng, Xianfeng Liu and Yongyan Wang.

NR03-1078 (AP/Tian)
Abstract P177

Carole Bullock | EurekAlert!
Further information:
http://www.americanheart.org/

More articles from Health and Medicine:

nachricht Hepatitis: liver failure attributable to compromised blood supply
19.12.2018 | Technische Universität München

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New megalibrary approach proves useful for the rapid discovery of new materials

Northwestern discovery tool is thousands of times faster than conventional screening methods

Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...

Im Focus: Data storage using individual molecules

Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.

Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Scientists to give artificial intelligence human hearing

19.12.2018 | Information Technology

Newly discovered adolescent star seen undergoing 'growth spurt'

19.12.2018 | Physics and Astronomy

From a plant sugar to toxic hydrogen sulfide

19.12.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>